Frankfurt, Germany:
Pfizer/BioNTech mentioned Friday they have asked European regulators to authorise their Covid-19 vaccine for 12 to 15-year-old, following a equivalent move in the United States earlier this month.
The providers have submitted a request with the European Medicines Agency (EMA) to expand the present emergency approval for their jab to contain “adolescents 12 to 15 years of age”, they mentioned in a statement.
BioNTech CEO Ugur Sahin mentioned Thursday the jab could be offered for these age groups from June.
()